lessons learned: co2 angiography in the oislessons learned: co2 angiography in the ois craig m....

28
Lessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine Tulane University School of Medicine New Orleans, LA Clinical Professor of Medicine LSU School of Medicine New Orleans, LA Founder, President, and Medical Director Cardiovascular Institute of the South Houma, LA Clinical Editor Vascular Disease Management Global Vascular Digest

Upload: others

Post on 26-May-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

Lessons Learned: CO2 Angiography in the OIS

Craig M. Walker, MD, FACC, FACPChairman, New Cardiovascular Horizons

Clinical Professor of MedicineTulane University School of MedicineNew Orleans, LA

Clinical Professor of MedicineLSU School of MedicineNew Orleans, LA

Founder, President, and Medical DirectorCardiovascular Institute of the SouthHouma, LA

Clinical EditorVascular Disease Management

Global Vascular Digest

Page 2: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

DisclosuresStockholder:

• Cardiva

Consultant/Medical/Scientific Boards:• Abbott

• Boston Scientific

• Cardiva

• CR Bard

• Lake Regional Medical

• Medtronic

• Philips Volcano

Speaker’s Bureau:• Abbott

• Bard

• Bristol-Myers-Squibb/Sanofi

• Cardiva

• Gore

• Philips Volcano

• Jannsen

PVD Training:• Abbott

• Bard

• Boston Scientific

• Philips Volcano

Page 3: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

PITFALLS OF IODINATED CONTRAST

• Contrast induced nephropathy and acute renal failure

– Rise of serum Cr 0.5 mg/dl

– Rise of serum Cr greater than 25% baseline

• Contrast allergy

• Highly viscous which may limit visualization of critically stenotic vessels and makes injection via long or small bore catheters difficult

Page 4: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

CIN (Contrast Induced Nephropathy)

• 3rd most common cause of hospital acquired acute renal failure (behind shock and nephrotoxic drugs).

• Dramatically increases mortality, morbidity, length of stay, and cost.

• Average increased cost $10,345 in hospital and $11,812 1st

year.

• Only absolute prevention is no iodinated contrast.

Nash et al; Am Jour Kidney Dis.Subramanion, S e tal; J Med Economics N:2007:119-134Dangas, G et al; AmJCardio. 95 2005:13-19Lindsey, J et al; AmJCardio. 94 2004:786-789

Page 5: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

From: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention:

Development and initial validationJ Am Coll Cardiol. 2004;44(7):1393-1399. doi:10.1016/j.jacc.2004.06.068

Scheme to define contrast-induced nephropathy (CIN) risk score. Anemia = baseline hematocrit value <39% for men and <36% for women; CHF =

congestive heart failure class III/IV by New York Heart Association classification and/or history of pulmonary edema; eGFR = estimated glomerular

filtration rate; hypotension = systolic blood pressure <80 mm Hg for at least 1 h requiring inotropic support with medications or intra-aortic

balloon pump (IABP) within 24 h periprocedurally.

Figure Legend:

INDEPENDENT CIN RISK FACTORS

Page 6: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

From: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development

and initial validationJ Am Coll Cardiol. 2004;44(7):1393-1399. doi:10.1016/j.jacc.2004.06.068

Figure Legend: The contrast-induced nephropathy risk score derived from the development dataset predicted this

complication in the validation set, as well. Blue bars = development dataset; Red bars = validation dataset.

7.5

14

26.1

57.3

8.4

12.8

29.9

55.9

0

10

20

30

40

50

60

70

Low Moderate High Very High

Co

ntr

ast

ind

uce

d n

ep

hro

pat

hy,

%

Risk score: = 5 6 to 10 11 to 15 ≥16Risk groups:

Page 7: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

0.04 0.121.09

12.6

0 0

1.4

13.4

0

2

4

6

8

10

12

14

16

Low Moderate High Very High

In-h

osp

ital

dia

lysi

s, %

Risk score: = 5 6 to 10 11 to 15 ≥16

Risk groups:

From: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention:

Development and initial validationJ Am Coll Cardiol. 2004;44(7):1393-1399. doi:10.1016/j.jacc.2004.06.068

In-hospital hemodialysis can be predicted by a high or very high risk score value similarly in the development

and validation datasets. Blue bars = development dataset; Red bars = validation dataset.

Figure Legend:

Risk of dialysis

Page 8: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

CIN RISK IS INCREASING IN PAD CASES

• Diabetes is epidemic

• More interventions are being performed

• More complex interventions (limb salvage)

• Older patients

Page 9: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

CONTRAST ALLERGY

• Minor allergies and Anaphylaxis

– Pre-medications required

– Patient apprehension

– Mortality risk

Page 10: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

GAS X-RAY IMAGES

• X-ray travels more easily through gas therefore the image is the negative of that created by iodinated agents.

• There is less contrast therefore motion severely impairs image quality.

Page 11: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

CHARACTERISITICS OF C02

• Non-toxic (no allergic response or nephrotoxicity)

• Non-flammable

• Buoyant

• Compressible

• Low viscosity

• Highly soluble (>40x more soluble than O2 which is far more soluble than nitrogen)

Page 12: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

OPTIMIZING CO2 IMAGES

• Requires DSA imaging.

• Use end-hole catheters (less bubbles). Place the catheter as close to the artery to be imaged as possible.

• Slow low-pressure injection

• Recognize that gravity affects imaging. May need to elevate lower leg, renal artery imaging may require rotation of patient if non-selective.

Page 13: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

Correlation with Iodinated Contrast

• Seeger demonstrated close correlation in peripheral arterial imaging.

– 92% when CO2 was utilized as sole agent

– 100% when supplemented by small doses of iodinated contrast.

Page 14: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

POSITIVES OF CO2

• No renal toxicity

• No dose limitations

• Can image via longer and smaller bore catheters because of less viscosity

• Less cost

Page 15: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

NEGATIVES OF CO2

• More radiation

• Must have CO2 settings

• Most systems don’t allow road mapping

• Motion artifact dramatically limits imaging

• Overlying gas may limit imaging

• May be sub-optimal in very large vessels

• Image quality slightly less crisp than iodinated contrast

• Can’t use to image cerebral or coronary vessels

Page 16: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

CO2 COMMANDER

Page 17: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 18: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 19: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 20: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 21: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 22: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 23: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 24: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 25: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine
Page 26: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

WHY CONSIDER C02 ANGIO

• Avoiding contrast induced nephropathy– Rise in serum Cr > .5 mg/dl– Rise of serum Cr > 25% baseline

• Avoiding severe allergic response• Lower viscosity

– Can image via smaller bore longer catheters– Can image with close tolerances (6F compatible device in 6F

sheath as example.)– Occasionally allows visualization of critically stenotic grafts that

appear totally occluded by iodinated contrast images.

• Cost– Two cents/cc vs. $1.00– Indirect costs (longer stays, meds, dialysis, etc.)

Page 27: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

CONCLUSION

• The only way to absolutely avoid CIN is to not administer iodinated contrast.

• In PAD there are viable options– External duplex guidance

– CO2 angiography- THIS HAS TOTALLY CHANGED MY PRACTICE• 1) No renal function too impaired

• 2) No limit on imaging – better results

• 3) No pre-admission or prolonged stay

• 4) Can image with smaller catheters (less viscous)

Page 28: Lessons Learned: CO2 Angiography in the OISLessons Learned: CO2 Angiography in the OIS Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine

Lessons Learned: CO2 Angiography in the OIS

Craig M. Walker, MD, FACC, FACPChairman, New Cardiovascular Horizons

Clinical Professor of MedicineTulane University School of MedicineNew Orleans, LA

Clinical Professor of MedicineLSU School of MedicineNew Orleans, LA

Founder, President, and Medical DirectorCardiovascular Institute of the SouthHouma, LA

Clinical EditorVascular Disease Management

Global Vascular Digest